These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1528038)

  • 1. Platelet activating factor antagonist enhances lung preservation.
    Corcoran PC; Wang Y; Katz NM; St Louis JD; Foegh ML; Rajan SS; Analouei AR; Wallace RB
    J Surg Res; 1992 Jun; 52(6):615-20. PubMed ID: 1528038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
    Corcoran PC; Wang Y; Katz NM; Rajan SS; Analouei AR; Foegh ML; Wallace RB
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):66-72. PubMed ID: 1614217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term lung preservation with the PAF antagonist BN 52021.
    Conte JV; Katz NM; Wallace RB; Foegh ML
    Transplantation; 1991 Jun; 51(6):1152-6. PubMed ID: 2048190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of conjugated dienes in lung transplantation: effect of BN 52021.
    Corcoran PC; Tse SS; Katz NM; Wang Y; St Louis JD; Foegh ML; Analouei AR; Wallace RB
    Ann Thorac Surg; 1993 Dec; 56(6):1279-83; discussion 1284. PubMed ID: 8267425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation.
    Wittwer T; Grote M; Oppelt P; Franke U; Schaefers HJ; Wahlers T
    J Heart Lung Transplant; 2001 Mar; 20(3):358-63. PubMed ID: 11257563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation.
    Hirt SW; Wahlers T; Jurmann M; Dammenhayn L; Rohde R; Haverich A
    Transpl Int; 1992; 5 Suppl 1():S374-8. PubMed ID: 14621825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron chelation therapy and lung transplantation. Effects of deferoxamine on lung preservation in canine single lung transplantation.
    Conte JV; Katz NM; Foegh ML; Wallace RB; Ramwell PW
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):1024-9. PubMed ID: 2038195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.
    Evans TW; McAnulty RJ; Rogers DF; Chung KF; Barnes PJ; Laurent GJ
    Environ Health Perspect; 1990 Apr; 85():65-9. PubMed ID: 1696541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. University of Wisconsin solution extends lung preservation after prostaglandin E1 infusion.
    Lin PJ; Hsieh MJ; Cheng KS; Kuo TT; Chang CH
    Chest; 1994 Jan; 105(1):255-61. PubMed ID: 8275743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the PAF antagonist BN 52021 in ovine endotoxin shock.
    Redl H; Vogl C; Schiesser A; Paul E; Thurnher M; Bahrami S; Schlag G
    J Lipid Mediat; 1990; 2 Suppl():S195-201. PubMed ID: 2133282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future horizons of lung preservation by application of a platelet-activating factor antagonist compared with current clinical standards. Euro-Collins flush perfusion versus donor core cooling.
    Wahlers T; Hirt SW; Haverich A; Fieguth HG; Jurmann M; Borst HG
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):200-4; discussion 205. PubMed ID: 1735984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation.
    Binns OA; DeLima NF; Buchanan SA; Cope JT; King RC; Marek CA; Shockey KS; Tribble CG; Kron IL
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1515-21. PubMed ID: 8975843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
    Pi F; Hotter G; Closa D; Roselló-Catafau J; Bulbena O; Badosa F; Morris M; Fernández-Cruz L; Gelpi E
    Transplantation; 1994 Jan; 57(1):12-7. PubMed ID: 8291097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model.
    Torras J; Bordalba JR; Seron D; Moliner R; Carrera M; Valles J; Martinez-Castelao A; Alsina J; Griño JM
    Transpl Int; 1993; 6(4):236-8. PubMed ID: 8347271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model.
    Castellvi J; Borobia FG; Figueras J; Fradera R; Herrero I; Torras J; Busquets J; Fabregat J; Jorba R; Jaurrieta E
    Transplant Proc; 2002 Feb; 34(1):50-2. PubMed ID: 11959181
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
    Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist.
    Braquet P; Bourgain RH
    Adv Exp Med Biol; 1987; 215():215-35. PubMed ID: 3314403
    [No Abstract]   [Full Text] [Related]  

  • 20. A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation.
    Qayumi KA; English JC; Feeley EJ; Poostizadeh A; Nikbakht-Sangari M
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):777-85. PubMed ID: 9512873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.